Matthew Winton

Overview

Matthew Winton received $2M in total compensation, including $326K in salary, at Inozyme Pharma in 2023.

Source: SEC filing on April 26, 2024.

Related executives

We found seven more executives who work or worked at Inozyme Pharma.

Douglas Treco

Inozyme Pharma

Chief Executive Officer

Axel Bolte

Inozyme Pharma

Chief Executive Officer

Sanjay Subramanian

Inozyme Pharma

Chief Financial Officer

Henric Bjarke

Inozyme Pharma

Chief Operating Officer

Deborah Wenkert

Inozyme Pharma

Chief Medical Officer

Steven Jungles

Inozyme Pharma

Former Senior Vice President and Chief Technical Operations Officer

Pedro Huertas

Inozyme Pharma

Chief Medical Officer

News

You may also like